<p>(<b>A, E</b>) To confirm knockdown of EZH2, RNA was extracted from the transfected lines and qPCR was performed. Expression in knockdown lines (E1) is shown relative to PLKO controls. (<b>B,F</b>) Confirmation of protein levels of EZH2 in the knockdown lines was performed using standard Western blotting methods. Both qPCR and Western blotting verified EZH2 levels were reduced by over 50% in HTB-175 and H524 cells upon shRNA-mediated knockdown. (<b>C,D,G,H</b>) To assess the viability of <i>EZH2</i> knockdown relative to controls cells we performed MTT assays. Knockdown of EZH2 caused a significant and reproducible decrease in cell viability in both SCLC cell lines (Student's t-test, p<0.05).</p
<p>Meanwhile, western blot analysis of EZH2 and E-cadherin were performed in CC cells treated with s...
<p><b>(A)</b> Western blot showing reduced global H3K27me3 levels in KARPAS-422 cells treated with 1...
<p>HPASMCs were transfected with a plasmid expressing EZH2 or control plasmids using 4D-Nucleofector...
<p>(<b>A</b>) Western blot showing the effect of EZH2 siRNA (si+) or a scrambled control siRNA (si-)...
<p>(A–B) EZH2 knockdown is efficient and specific. MDA MB 435, 435-Brain 1, and 435-Lung 2 cells wer...
<p>(A) EZH2 expression in NSCLC lung cancer cells and human bronchial epithelia cells (HBEs) were de...
<p>(A, B) Proliferation plot of cells with down-regulated EZH2. A549 or 1299 were transfected with E...
<p>(<b>A</b>, <b>B</b>) Phase contrast images show that pOLs retract their projections when treated ...
<p><b>A </b><i>EZH2</i> transcript expression was decreased 24 h after si<i>EZH2</i> treatment (left...
<p>A549 or 1299 were transfected with EZH2-targeting siRNA or scrambled siRNA control for 6 hours. (...
<p>(A–C) The siRNA knockdown efficiency was evaluated by testing the protein level of EZH2. EZH2 siR...
<p>(A, B) Representative western blot analysis of EZH2 after GSK3β-KD (2 μg/mL) or control plasmid t...
<p>H1299 (A) or A549 (B) cells were transfected with EZH2-targeting siRNA or scrambled siRNA control...
<p>(A–B) MDA MB 435 variants were transfected with either EZH2 specific siRNA or with control siRNA ...
<p>Meanwhile, western blot analysis of EZH2 and E-cadherin were performed in CC cells treated with s...
<p>Meanwhile, western blot analysis of EZH2 and E-cadherin were performed in CC cells treated with s...
<p><b>(A)</b> Western blot showing reduced global H3K27me3 levels in KARPAS-422 cells treated with 1...
<p>HPASMCs were transfected with a plasmid expressing EZH2 or control plasmids using 4D-Nucleofector...
<p>(<b>A</b>) Western blot showing the effect of EZH2 siRNA (si+) or a scrambled control siRNA (si-)...
<p>(A–B) EZH2 knockdown is efficient and specific. MDA MB 435, 435-Brain 1, and 435-Lung 2 cells wer...
<p>(A) EZH2 expression in NSCLC lung cancer cells and human bronchial epithelia cells (HBEs) were de...
<p>(A, B) Proliferation plot of cells with down-regulated EZH2. A549 or 1299 were transfected with E...
<p>(<b>A</b>, <b>B</b>) Phase contrast images show that pOLs retract their projections when treated ...
<p><b>A </b><i>EZH2</i> transcript expression was decreased 24 h after si<i>EZH2</i> treatment (left...
<p>A549 or 1299 were transfected with EZH2-targeting siRNA or scrambled siRNA control for 6 hours. (...
<p>(A–C) The siRNA knockdown efficiency was evaluated by testing the protein level of EZH2. EZH2 siR...
<p>(A, B) Representative western blot analysis of EZH2 after GSK3β-KD (2 μg/mL) or control plasmid t...
<p>H1299 (A) or A549 (B) cells were transfected with EZH2-targeting siRNA or scrambled siRNA control...
<p>(A–B) MDA MB 435 variants were transfected with either EZH2 specific siRNA or with control siRNA ...
<p>Meanwhile, western blot analysis of EZH2 and E-cadherin were performed in CC cells treated with s...
<p>Meanwhile, western blot analysis of EZH2 and E-cadherin were performed in CC cells treated with s...
<p><b>(A)</b> Western blot showing reduced global H3K27me3 levels in KARPAS-422 cells treated with 1...
<p>HPASMCs were transfected with a plasmid expressing EZH2 or control plasmids using 4D-Nucleofector...